North Star Investment Management’s Definium Therapeutics DFTX Stock Holding History

North Star Investment Management’s Portfolio DFTX Stock Details DFTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$403K	Buy	8,571 +1,000	+13%	+$24.7K	0.02%	426
2026 Q1	$143K	Buy	7,571 +870	+13%	+$14.8K	0.01%	546
2025 Q4	$89.7K	Hold	6,701	–	–	0.01%	569
2025 Q3	$79K	Hold	6,701	–	–	0.01%	573
2025 Q2	$43.5K	Sell	6,701 -2,700	-29%	-$17.8K	﹤0.01%	664
2025 Q1	$55K	Hold	9,401	–	–	﹤0.01%	596
2024 Q4	$65.4K	Hold	9,401	–	–	﹤0.01%	573
2024 Q3	$53.5K	Buy	9,401 +6,901	+276%	+$48K	﹤0.01%	585
2024 Q2	$18K	Buy	2,500 +350	+16%	+$3.06K	﹤0.01%	734
2024 Q1	$20.2K	Buy	+2,150	New	+$12.3K	﹤0.01%	741
2023 Q4	–	Sell	-14,860	Closed	-$46.5K	–	1257
2023 Q3	$46.5K	Buy	14,860 +2,810	+23%	+$11.6K	﹤0.01%	596
2023 Q2	$43K	Buy	12,050 +2,925	+32%	+$10.1K	﹤0.01%	630
2023 Q1	$28.9K	Buy	9,125 +9,092	+27,552%	+$30.2K	﹤0.01%	707
2022 Q4	$73	Hold	33	–	–	﹤0.01%	1299
2022 Q3	$0	Sell	33 -907	-96%	-$8.71K	﹤0.01%	1161
2022 Q2	$9K	Buy	+940	New	+$11.9K	﹤0.01%	851

Other funds holding DFTX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

North Star Investment Management's DFTX Position: Q2 2026 in Review

North Star Investment Management increased its Definium Therapeutics (DFTX) stake by 13% in Q2 2026, buying an estimated $24.7K and bringing the position to 8,571 shares worth $403K. The position accounts for 0.02% of the portfolio, ranked #426.

North Star Investment Management first reported a position in DFTX in Q2 2022 and has held it in 16 quarters since. 362 funds tracked by Wall St. Rank hold DFTX as of Q2 2026.

North Star Investment Management held 8,571 shares of Definium Therapeutics worth $403K as of Q2 2026.
North Star Investment Management bought 1,000 Definium Therapeutics shares in Q2 2026, an estimated $24.7K.
Definium Therapeutics made up 0.02% of North Star Investment Management's portfolio in Q2 2026, its #426 holding.
North Star Investment Management first reported a position in Definium Therapeutics in Q2 2022 and has held it in 16 quarters since.
362 funds tracked by Wall St. Rank held Definium Therapeutics as of Q2 2026.

Based on North Star Investment Management's 13F filing for Q2 2026, filed 28 Jul 2026.